Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 18 Carcinoma, Non-Small-Cell Lung 14 Colorectal Neoplasms 11 Lung Neoplasms 9 Recurrence 7 Neoplasm Metastasis 5 Colonic Neoplasms 5 Breast Neoplasms 5 Rectal Neoplasms 4 Ovarian Neoplasms 4 Lymphoma, T-Cell, Peripheral 4 Infertility 4 Neoplasms 3 Lymphoma, T-Cell 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Sezary Syndrome 2 Papillomavirus Infections 2 Mycosis Fungoides 2 Meningeal Carcinomatosis 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, B-Cell 2 Lymphoma 2 Insulin Resistance 2 Infertility, Female 2 Hyperandrogenism 2 Head and Neck Neoplasms 2 Diabetes, Gestational 2 Carcinoma, Transitional Cell 2 Atypical Squamous Cells of the Cervix 2

Interventions

Oxaliplatin 295 Capecitabine 209 Fluorouracil 183 Cisplatin 172 Docetaxel 140 S 1 (combination) 135 Paclitaxel 128 Leucovorin 117 Irinotecan 110 pembrolizumab 104 Trastuzumab 76 Nivolumab 59 apatinib 57 Drug Therapy 52 sintilimab 46 Surgical Procedures, Operative 45 Ramucirumab 40 Radiotherapy 40 Bevacizumab 37 Hyperthermic Intraperitoneal Chemotherapy 34 Epirubicin 32 titanium silicide 31 tislelizumab 31 Carboplatin 31 Gastrectomy 28 Cyclophosphamide 27 XELOX 25 Tegafur 24 Folfox protocol 23 Albumin-Bound Paclitaxel 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × Folic Acid × Clear all

NCT04062656 2024-03-12

IMAGINE

University Hospital, Essen

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡